DAP:ETR
Danaher Corp
204,70 €
arrow_downward
-0,49%(-1,00) 1 d.
6. nov., 17:35:52 GMT+1 · EUR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: DAP…
Atvērt
201,60 €
Augsta
204,70 €
Zema
198,45 €
Tirgus kapitalizācija
161,99 mljrd.
Vid. apjoms
567,00
Apjoms
1,43 tūkst.
Augstākā 52 ned.
214,50 €
Zemākā 52 ned.
138,20 €
Darbinieku skaits
59 tūkst.
Atvērt
201,60 €
Augsta
204,70 €
Zema
198,45 €
Tirgus kapitalizācija
161,99 mljrd.
Vid. apjoms
567,00
Apjoms
1,43 tūkst.
Augstākā 52 ned.
214,50 €
Zemākā 52 ned.
138,20 €
Darbinieku skaits
59 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Yahoo Finance
·
pirms 2 dienām
Danaher (DHR) Stock Looks Fully Priced Despite Its 18% Three Year Gain
Profils
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Par “Danaher Corp”
ĢenerāldirektorsRainer M. Blair
Darbinieki59 tūkst.
Dibināšanas datums1969
Galvenais birojs-
SektorsHealth Care
Nozare-
Tīmekļa vietnedanaher.com